Regulation of liver cytochrome P450 by activation of brain dopaminergic system: Physiological and pharmacological implications

Biochemical Pharmacology

Volumn 76, Issue 2, 2008, Pages 258-267

  Wójcikowski, Jacek ^a   Gołembiowska, Krystyna ^a   Daniel, Władysława Anna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Activation; Brain dopaminergic system; Liver cytochrome P450; Plasma hormone levels

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; AMPHETAMINE; APOMORPHINE; CORTICOSTERONE; CYTOCHROME P450; CYTOCHROME P450 2B; CYTOCHROME P450 2C11; CYTOCHROME P450 3A; DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR; GROWTH HORMONE; INTERLEUKIN 2; INTERLEUKIN 6; ISOENZYME; LIOTHYRONINE; QUINPIROLE; TESTOSTERONE; THYROXINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; ENZYME ACTIVATION; ENZYME REGULATION; HORMONE BLOOD LEVEL; HYPOPHYSIS; LIMBIC CORTEX; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUBEROHYPOPHYSEAL TRACT;

ANIMALS; BRAIN; CYTOCHROME P-450 ENZYME SYSTEM; DOPAMINE AGENTS; HORMONES; INTERLEUKIN-2; INTERLEUKIN-6; MALE; MICROSOMES, LIVER; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2;

EID: 45649083697     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.04.016     Document Type: Article

References (53)

1. Miksys S., and Tyndale R.F. The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics. Drug Metab Rev 36 (2004) 313-333
2. Meyer R.P., Gehlhaus M., Knoth R., and Volk B. Expression and function of cytochrome P450 in brain drug metabolism. Curr Drug Metab 8 (2007) 297-306
3. Honkakoski P., and Negishi M. Regulation of cytochrome P450 genes by nuclear receptors. Biochem J 347 (2000) 321-337
4. Powell E.W., and Leman R.B. Connections of the nucleus accumbens. Brain Res 105 (1976) 389-403
5. Williams D.J., Crossman A.R., and Slater P. The efferent projections of the nucleus accumbens in the rat. Brain Res 130 (1977) 217-227
6. Hokfelt T., Fuxe K., Johansson O., Jeffcoate S., and White N. Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Eur J Pharmacol 134 (1975) 389-392
7. Sawchenko P.E. Evidence for differential regulation of corticotropin-releasing factor and vasopressin immunoreactivities in parvocellular neurosecretory and autonomic-related projections of the paraventricular nucleus. Brain Res 437 (1987) 253-263
8. Seeman P., and van Tol H.H.M. Dopamine receptor pharmacology. Trends Pharmacol Sci 15 (1994) 264-267
9. Boyson S.J., McGonigle P., and Molinoff P.B. Quantitative autoradiographic localization of D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci 6 (1986) 3177-3188
10. Dawson G.R., Gehlert D.R., McCabe R.T., Barnett A., and Wamsley J.K. Quantitative autoradiographic localization of central dopamine D-1 and D-2 receptors. J Neurosci 6 (1986) 2352-2365
11. Meador-Woodruff J.H., Mansour A., Healy D.J., Kuehn R., Zhou Q.Y., Bunzow J.R., et al. Comparison of the distributions of D1 and D2 dopamine receptors mRNAs in rat brain. Neuropsychopharmacology 5 (1991) 231-242
12. De Souza E.B. Dopamine receptors in the anterior lobe of the human pituitary gland: autoradiographic localization. Endocrinology 119 (1986) 1534-1542
13. Wamsley J.K., Gehlert D.R., Filloux F.M., and Dawson T.M. Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain. J Chem Neuroanat 2 (1989) 119-137
14. Mengod G., Villaró M.T., Landwehrmeyer G.B., Martinez-Mir M.I., Niznik H.B., Sunahara R.K., et al. Vizualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain. Neurochem Int 20 Suppl. (1992) 33S-43S
15. 3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study. J Pharmacol Exp Ther 264 (1993) 991-1001
16. Bansal S.A., Lee L.A., and Woolf P.D. Dopaminergic stimulation and inhibition of growth hormone secretion in normal man: studies of the pharmacologic specificity. J Clin Endocrinol Metab 53 (1981) 1273-1277
17. Fuller R.W., and Snoddy H.D. Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists. Endocrinology 109 (1981) 1026-1032
18. Morley J.E., Brammer G.L., Sharp B., Yamada T., and Yuwiler A. Neurotransmitter control of hypothalamic-pituitary-thyroid function in rats. Eur J Pharmacol 70 (1981) 263-271
19. Schuetz E.G., Wrighton S.A., Barwick J.L., and Guzelian P.S. Induction of cytochrome P450 by glucocorticoids in rat liver. J Biol Chem 259 (1984) 1999-2006
20. Waxman D.J., Ram P.A., Notani G., LeBlanc G.A., Alberta J.A., Morrissey J.J., et al. Pituitary regulation of the male-specific steroid 6β-hydroxylase P-450 2a (gene product IIIA2) in adult rat liver. Suppresive influence of growth hormone and thyroxine acting at a pretranslational level. Mol Endocrinol 4 (1990) 447-454
21. Murayama N., Shimada M., Yamazoe Y., and Kato R. Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system. Mol Pharmacol 39 (1991) 811-817
22. Liddle C., Goodwin B.J., George J., Tapner M., and Farrell G. Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab 83 (1998) 2411-2416
23. Pascussi J.-M., Gerbal-Chaloin S., Drocourt L., Assenat E., Larrey D., Pichard-Garcia L., et al. Cross-talk between xenobiotic detoxication and other signaling pathways: clinical and toxicological consequences. Xenobiotica 34 (2004) 633-664
24. Monostory K., Kohalmy K., Prough R.A., Kóbori L., and Vereczkey L. The effect of synthetic glucocorticoid, dexamethasone on CYP1A1 inducibility in adult rat and human hepatocytes. FEBS Lett 579 (2005) 229-235
25. Cerveny L., Svecova L., Anzenbacherova E., Vrzal R., Staud F., Dvorak Z., et al. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab Dispos 35 (2007) 1032-1041
26. Kohalny K., Tamási V., Kóbori L., Sárváry E., Pascussi J.M., Porrogi P., et al. Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor. Drug Metab Dispos 35 (2007) 1495-1501
27. Choi H.K., and Waxman D.J. Plasma growth hormone pulse activation of hepatic JAK-STAT5 signaling: developmental regulation and role in male-specific liver gene expression. Endocrinology 141 (2000) 3245-3255
28. Wójcikowski J., Gołembiowska K., and Daniel W.A. The regulation of liver cytochrome P450 by the brain dopaminergic system. Curr Drug Metab 8 (2007) 631-638
29. Takeuchi K., Nishiwaki H., and Okabe S. Effects of dopamine on gastric mucosal lesions induced by ethanol in rats. Possible involvement of antigastric motor activity mediated with alpha 2-adrenoceptors. Dig Dis Sci 33 (1988) 1560-1568
30. Lacroix L., Broersen L.M., Feldon J., and Weiner I. Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity. Behav Brain Res 107 (2000) 111-121
31. De Bruin N.M.W.J., Ellenbroek B.A., van Luijtelaar E.L.J.M., Cools A.R., and Stevens K.E. Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell. Neuroscience 105 (2001) 169-180
32. Zarrindast M.-R., Azami B.-N., Rostami P., and Rezayof A. Repeated administration of dopaminergic agents in the nucleus accumbens and morphine-induced place preference. Behav Brain Res 169 (2006) 248-255
33. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1998), Academic Press, San Diego
34. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin fenol reagent. J Biol Chem 193 (1951) 265-275
35. Daniel W.A., Syrek M., Ryłko Z., and Wójcikowski J. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes. Pol J Pharmacol 53 (2001) 351-357
36. Kot M., and Daniel W.A. Relative contribution of rat cytochrome P450 isoforms to the metabolism of caffeine: the pathway and concentration dependence. Biochem Pharmacol 75 (2008) 1538-1549
37. Haduch A., Wójcikowski J., and Daniel W.A. The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A. Eur Neuropsychopharmacol 16 (2006) 178-186
38. Wong Y.N. Analysis of corticosterone in rat plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl 661 (1994) 211-218
39. Tuomisto J., and Männistö P. Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 37 (1985) 249-332
40. Walters J.R., Bergstrom D.A., Carlson J.H., Chase T.N., and Braun A.R. D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Science 236 (1987) 719-722
41. Eliam D., Talangbayan H., Canaran G., and Szechtman H. Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors. Psychopharmacology 106 (1992) 447-454
42. Wachtel S.R., Brooderson R.J., and White F.J. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat. Psychopharmacology 109 (1992) 41-48
43. Agrawal A.K., and Shapiro B.H. Differential expression of gender-dependent hepatic isoforms of cytochrome P-450 by pulse signals in the circulating masculine episodic growth hormone profile of the rat. J Pharmacol Exp Ther 292 (2000) 228-237
44. Pampori N.A., Agrawal A.K., and Shapiro B.H. Infusion of gender-dependent plasma growth hormone profiles into intact rats: effects of subcutaneous, intraperitoneal, and intravenous routes of rat and human growth hormone on endogenous circulating growth hormone profiles and expression of sexually dimorphic hepatic CYP isoforms. Drug Metab Dispos 29 (2001) 8-16
45. Devesa J., Barros M.G., Gondar M., Tresguerres J.A.F., and Arce V. Regulation of hypothalamic somatostatin by glucocorticoids. J Steroid Biochem Mol Biol 53 (1995) 277-282
46. Iber H., Chen Q., Sewer M., and Morgan E.T. Regulation of hepatic cytochrome P450 2C11 by glucocorticoids. Arch Biochem Biophys 343 (1997) 305-310
47. Miller T.L., and Mayo K.E. Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression. Endocrinology 138 (1997) 2458-2465
48. Ohyama T., Sato M., Ohye H., Murao K., Nimi M., and Takahara J. Effects of adrenalectomy and glucocorticoid receptor antagonist, RU38486, on pituitary growth hormone-releasing hormone receptor gene expression in rats. Peptides 19 (1998) 1063-1067
49. Sérée E., Villard P.-H., Pascussi J.-M., Pineau T., Maurel P., Nguyen Q.B., et al. Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites. Gastroenterology 127 (2004) 1436-1445
50. Hunter J., Kassam A., Winrow C.J., Rachubinski R.A., and Capone J.P. Crosstalk between the thyroid hormone and peroxisome proliferator-activated receptors in regulating peroxisome proliferator-responsive genes. Mol Cell Endocrinol 116 (1996) 213-221
51. Bertou F., Guillois B., Riche C., Dreano Y., Jacqz-Aigrain E., and Beaune P.H. Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica 22 (1986) 671-680
52. Rane A., Liu Z., Levol R., Bjelfman C., Thyr C., Ericson H., et al. Differential effects of neuroleptic agents on hepatic cytochrome P-450 isoenzymes in the male rat. Biochem Biophys Acta 1291 (1996) 60-66
53. Daniel W.A. The influence of the long-term treatment with psychotropic drugs on cytochrome P450: the involvment of different mechanisms. Exp Opin Drug Metab Toxicol 1 (2005) 203-217